...
首页> 外文期刊>HPB: the official journal of the International Hepato Pancreato Biliary Association >Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma
【24h】

Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma

机译:晚期肺门胆管癌患者的光动力疗法与单独胆道支架置入术的长期结果

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: This study aimed to determine longterm outcomes and factors associated with increased survival after photodynamic therapy (PDT) compared with endoscopic biliary drainage alone in patients presenting with advanced hilar cholangiocarcinoma (CC). Methods: A retrospective analysis of the institutional database identifying all patients who presented with a diagnosis of hilar CC between December 1999 and January 2011 was conducted. Results: Of the 232 patients identified, 72 (31%) were treated with PDT (Group A) and 71 (31%) were treated with endoscopic biliary drainage alone (Group B). Median survival was 9.8 months [95% confidence interval (CI) 7.42-12.25] in Group A and 7.3 months (95% CI 4.79-9.88) in Group B (P= 0.029). On multivariate analysis, biliary drainage without PDT (P= 0.025) and higher T-stage (P= 0.002) were significant predictors of shorter survival in all patients. In a subgroup analysis of patients in the PDT group, lower pre-PDT bilirubin level (P= 0.005), multiple PDT treatments (P= 0.044) and shortened time to treatment after diagnosis (P= 0.013) were significant predictors of improved survival. Median metal stent patency was longer in Group A than in Group B (215 days vs. 181 days; P= 0.018). Conclusions: Photodynamic therapy with stenting resulted in longer survival than stenting alone. Early PDT after diagnosis and multiple PDT treatments were shown to have survival benefits. Metal stent patency was longer in patients receiving PDT. Higher T-stage appears to be a predictor of early mortality in advanced bile duct cancer treated with PDT.
机译:目的:本研究旨在确定晚期肝门胆管癌(CC)患者的光动力疗法(PDT)与单纯内镜胆道引流相比,长期结果和与生存率增加相关的因素。方法:对机构数据库进行回顾性分析,确定1999年12月至2011年1月期间所有诊断为肺门CC的患者。结果:在确定的232例患者中,有72例(31%)接受了PDT治疗(A组),有71例(31%)接受了内镜下胆道引流治疗(B组)。 A组中位生存期为9.8个月[95%置信区间(CI)7.42-12.25],B组中位生存期为7.3个月(95%CI 4.79-9.88)(P = 0.029)。在多因素分析中,无PDT的胆道引流(P = 0.025)和较高的T期(P = 0.002)是所有患者生存期缩短的重要预测指标。在PDT组患者的亚组分析中,PDT前胆红素水平降低(P = 0.005),PDT多次治疗(P = 0.044)和诊断后治疗时间缩短(P = 0.013)是存活率提高的重要预测指标。 A组中位金属支架通畅时间长于B组(215天vs. 181天; P = 0.018)。结论:支架置入光动力疗法比单独置入支架可获得更长的生存期。诊断后早期PDT和多次PDT治疗被证明具有生存益处。接受PDT的患者的金属支架通畅时间更长。较高的T期似乎是PDT治疗的晚期胆管癌早期死亡率的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号